Dealert› Deals› Pharmacy2U

G Square Healthcare Private Equity LLP, Coller Capital → Pharmacy2U

Other Private Equity United Kingdom Drug Retailers (NEC) Other / Unspecified
Deal summary

Information on the target

Pharmacy2U, founded in 1999, is the UK's largest online pharmacy, serving over two million patients and dispensing more than 3.5 million items each month. The company has established a leading digital pharmacy platform that integrates a wide range of NHS and private health services, as well as consumer and pet health products. With a strong commitment to innovation and patient care, Pharmacy2U has transformed the landscape of repeat prescriptions and online healthcare services in the UK.

Since G Square Healthcare Private Equity LLP's investment in 2018, Pharmacy2U has experienced remarkable growth, with both revenue and EBITDA increasing more than tenfold. This growth has been fueled by significant investments in proprietary technology, large-scale dispensing automation, and a strategic buy-and-build approach that has seen six acquisitions completed and integrated over the past two years.

Industry overview in the target’s specific country

The Drug Retailers (NEC) industry in the UK has undergone significant transformation in recent years, driven by technological advancements and changing consumer preferences. The rise of digital health solutions has reshaped the way patients access medications and healthcare services, leading to an increased demand for online pharmacy platforms. As a result, traditional brick-and-mortar pharmacies are adapting to compete with digital-first players like Pharmacy2U.

In the UK, the regulatory environment for drug retailers is robust, ensuring that patient safety and quality of care remain paramount. The National Health Service (NHS) plays a crucial role in this sector, providing a framework for prescription services and healthcare delivery. The integration of technology into pharmacy operations has not only improved efficiency but also enhanced patient experiences, allowing for more personalized and accessible healthcare solutions.

Moreover, the COVID-19 pandemic accelerated the adoption of online pharmacy services, as patients sought safer alternatives to in-person visits. This shift has prompted increased investment in digital health technologies and has positioned companies like Pharmacy2U at the forefront of the industry. As the market continues to evolve, there are significant opportunities for growth, particularly in expanding clinical services and enhancing technology-driven patient engagement.

Looking ahead, the Drug Retailers (NEC) industry in the UK is expected to continue its upward trajectory, with ongoing innovations in telehealth and digital pharmacy solutions. …

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗